Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Commentary

Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression

Online download statistics by month:

Online download statistics by month: February 2017 to April 2023

	Abstract	Full	Pdf
Feb 2017	49	3	4
Mar 2017	300	80	73
Apr 2017	90	21	15
May 2017	51	28	17
Jun 2017	64	24	12
Jul 2017	111	24	20
Aug 2017	604	78	65
Sep 2017	199	27	21
Oct 2017	147	28	25
Nov 2017	104	16	12
Dec 2017	94	17	11
Jan 2018	124	12	9
Feb 2018	96	15	8
Mar 2018	121	21	12
Apr 2018	145	19	9
May 2018	123	8	6
Jun 2018	95	3	11
Jul 2018	109	7	7
Aug 2018	50	1	2
Sep 2018	70	4	4
Oct 2018	72	9	19
Nov 2018	44	6	7
Dec 2018	41	7	6
Jan 2019	68	6	10
Feb 2019	35	9	9
Mar 2019	30	5	5
Apr 2019	37	2	4
May 2019	56	6	6
Jun 2019	33	5	4
Jul 2019	54	4	0
Aug 2019	60	0	0
Sep 2019	24	2	1
Oct 2019	51	10	4
Nov 2019	42	8	3
Dec 2019	16	2	1
Jan 2020	37	3	1
Feb 2020	57	3	2
Mar 2020	44	3	3
Apr 2020	14	0	0
May 2020	20	1	1
Jun 2020	34	7	2
Jul 2020	42	7	1
Aug 2020	15	1	1
Sep 2020	64	0	0
Oct 2020	47	5	1
Nov 2020	53	6	6
Dec 2020	48	5	3
Jan 2021	28	0	0
Feb 2021	51	5	0
Mar 2021	49	3	1
Apr 2021	63	2	1
May 2021	55	7	2
Jun 2021	7	7	2
Jul 2021	3	3	0
Aug 2021	1	1	0
Sep 2021	4	3	0
Oct 2021	99	2	1
Nov 2021	97	6	3
Dec 2021	40	5	0
Jan 2022	82	8	3
Feb 2022	74	6	0
Mar 2022	89	8	4
Apr 2022	68	13	2
May 2022	132	8	1
Jun 2022	141	1	1
Jul 2022	93	4	2
Aug 2022	125	3	0
Sep 2022	180	16	5
Oct 2022	201	17	2
Nov 2022	109	6	2
Dec 2022	134	5	4
Jan 2023	88	2	0
Feb 2023	197	7	4
Mar 2023	158	8	6
Apr 2023	227	7	0
Total	6479	721	489